Sopharma AD (BUL:SFA)

Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of BGN 1.92 billion. The enterprise value is 2.47 billion.

Market Cap	1.92B
Enterprise Value	2.47B

Important Dates

The next confirmed earnings date is Monday, June 1, 2026.

Earnings Date	Jun 1, 2026
Ex-Dividend Date	Dec 18, 2025

Share Statistics

Sopharma AD has 525.53 million shares outstanding. The number of shares has increased by 6.70% in one year.

Current Share Class	525.53M
Shares Outstanding	525.53M
Shares Change (YoY)	+6.70%
Shares Change (QoQ)	+38.16%
Owned by Insiders (%)	10.06%
Owned by Institutions (%)	0.29%
Float	165.52M

Valuation Ratios

The trailing PE ratio is 11.95.

PE Ratio	11.95
Forward PE	n/a
PS Ratio	0.71
PB Ratio	1.86
P/TBV Ratio	2.54
P/FCF Ratio	51.60
P/OCF Ratio	23.53
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.06, with an EV/FCF ratio of 66.42.

EV / Earnings	15.98
EV / Sales	0.91
EV / EBITDA	9.06
EV / EBIT	12.75
EV / FCF	66.42

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.54.

Current Ratio	1.38
Quick Ratio	0.73
Debt / Equity	0.54
Debt / EBITDA	2.38
Debt / FCF	14.92
Interest Coverage	7.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.37%
Return on Capital Employed (ROCE)	12.26%
Weighted Average Cost of Capital (WACC)	4.43%
Revenue Per Employee	453,840
Profits Per Employee	26,096
Employee Count	5,932
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sopharma AD has paid 13.51 million in taxes.

Income Tax	13.51M
Effective Tax Rate	7.72%

Stock Price Statistics

The stock price has increased by +65.64% in the last 52 weeks. The beta is 0.07, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	+65.64%
50-Day Moving Average	1.78
200-Day Moving Average	1.58
Relative Strength Index (RSI)	59.65
Average Volume (20 Days)	71,223

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of BGN 2.69 billion and earned 154.80 million in profits. Earnings per share was 0.30.

Revenue	2.69B
Gross Profit	664.11M
Operating Income	155.87M
Pretax Income	175.11M
Net Income	154.80M
EBITDA	230.05M
EBIT	155.87M
Earnings Per Share (EPS)	0.30

Balance Sheet

The company has 42.51 million in cash and 555.43 million in debt, with a net cash position of -512.92 million or -0.98 per share.

Cash & Cash Equivalents	42.51M
Total Debt	555.43M
Net Cash	-512.92M
Net Cash Per Share	-0.98
Equity (Book Value)	1.03B
Book Value Per Share	0.99
Working Capital	297.08M

Cash Flow

In the last 12 months, operating cash flow was 81.66 million and capital expenditures -44.43 million, giving a free cash flow of 37.24 million.

Operating Cash Flow	81.66M
Capital Expenditures	-44.43M
Depreciation & Amortization	74.18M
Net Borrowing	1.55M
Free Cash Flow	37.24M
FCF Per Share	0.07

Margins

Gross margin is 24.67%, with operating and profit margins of 5.79% and 5.75%.

Gross Margin	24.67%
Operating Margin	5.79%
Pretax Margin	6.50%
Profit Margin	5.75%
EBITDA Margin	8.55%
EBIT Margin	5.79%
FCF Margin	1.38%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 1.53%.

Dividend Per Share	0.06
Dividend Yield	1.53%
Dividend Growth (YoY)	205.42%
Years of Dividend Growth	1
Payout Ratio	28.47%
Buyback Yield	-6.70%
Shareholder Yield	-5.17%
Earnings Yield	8.06%
FCF Yield	1.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 10, 2025. It was a forward split with a ratio of 3.

Last Split Date	Jul 10, 2025
Split Type	Forward
Split Ratio	3

Scores

Altman Z-Score	n/a
Piotroski F-Score	3